Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-myristoyltransferase (NMT)1, NMT2 and methionine aminopeptidase 2 overexpression in peripheral blood and peripheral blood mononuclear cells is a marker for adenomatous polyps and early detection of colorectal cancer

N-myristoyltransferase (NMT)1, NMT2 and methionine aminopeptidase 2 overexpression in peripheral blood and peripheral blood mononuclear cells is a marker for adenomatous polyps and early detection of colorectal cancer

US Patent 12024748 · Granted Jul 2, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Predicting prognosis and treatment response of breast cancer patients using expr2024
Methionine aminopeptidase overexpression in the peripheral blood and peripheral 2022
Methionine aminopeptidase overexpression in the peripheral blood and peripheral 2022
Use of N-myristoyltransferase on non-tumor tissue for cancer diagnosis2011